Fibromyalgia is a chronic condition characterized by widespread pain, fatigue, and tender points. It affects about 2-5% of the population worldwide. Current treatment options aim to relieve symptoms and improve quality of life. This includes medications like antidepressants, anti-seizure drugs, analgesics and therapies like exercise and relaxation. The market offers a wide range of prescription and over-the-counter drugs used to manage fibromyalgia.

Market key trends:

Increasing prevalence of fibromyalgia is a major trend fueling market growth. A significant rise in fibromyalgia diagnoses has been witnessed globally in the last decade. Other factors like growing awareness, evolving treatment landscape and strong research & development are also contributing to industry expansion. Additionally, the market is witnessing a shift towards combination therapies using drugs coupled with non-drug therapies. Emerging biological and pipeline drugs also hold promising potential to widen treatment options.

Porter's Analysis

Threat of new entrants: The threat of new entrants is moderate. High capital requirements for R&D and clinical trials pose a barrier. However, large market size and growing demand attract new players.
Bargaining power of buyers: The bargaining power of buyers is moderate. The availability of alternative treatment options provides some bargaining power to buyers.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to the specialized nature of manufacturing APIs and formulations for fibromyalgia treatment.
Threat of new substitutes: The threat of new substitutes is high due to ongoing research on new targets and mechanisms for treating fibromyalgia.
Competitive rivalry: Intense due to the large market size and expected growth.

SWOT Analysis

Strength: Growing prevalence of fibromyalgia and high unmet needs. Existing drugs provide a base for research and development in the area.
Weakness: Lack of approved drugs that provide long term remission. High development costs associated with R&D.
Opportunity: Increasing awareness about fibromyalgia and its management. Emerging economies provide scope for market expansion.
Threats: Strong pipeline of competing drugs. Stringent regulatory environment for drug approvals.

Key Takeaways

The Global Fibromyalgia Treatment Market Size is expected to witness high growth, exhibiting CAGR of 3.3% over the forecast period, due to increasing awareness regarding fibromyalgia disorder. The growing prevalence of fibromyalgia across the globe due to changing lifestyles and increasing stress levels also drives the market growth.

Regionally, North America dominates the global market and is expected to continue its dominance over the forecast period. This is attributed to the growing fibromyalgia patient pool, high healthcare expenditure, availability of advanced treatment options and favorable reimbursement policies in the region.

For More Insights, Read- https://www.feedsfloor.com/pharmaceuticals/fibromyalgia-treatment-market-growing-market-owing-increasing-prevalence